Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient

Pain, Chronic Clinical Trial

Official title:

Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient: A Prospective Non-randomized Study.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05628246
• Other study ID #: Si 310/2022
• Status: Recruiting
• Phase: N/A
• Start date: January 19, 2023
• Est. completion date: July 17, 2025

Study information

• Verified date: January 2023
• Source: Mahidol University
• Contact: Suratsawadee Wangnamthip, M.D.
• Phone: +66-81-926-1509
• Email: suratsawadee.wan[@]mahidol.ac.th
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cancer is the second leading cause of death worldwide, with approximately 18.1 million new cases and 9.6 million deaths reported in 2018. Cancer-related pain is experienced by 50-70% of patients, with a higher prevalence at advanced disease stages (66.4%). Since the development of WHO's cancer pain guidelines, several studies have reported good relief of symptoms and suffering for a majority of patients. Recent reports suggest that up to 50% of patients still report insufficient pain control. Patients with cancer often present with multiple symptoms and functional decline. Evidence supports multidisciplinary approaches to address symptoms and suffering, including early palliative care referral

From review literatures we found that the telemedicine group had significantly higher quality of life than the usual care group. In addition, the telemedicine group had lower anxiety and depression scores than the usual care group.

Therefore, we will conduct the non-randomized controlled study of using telemedicine comparing to conventional in-person at OPD in hospitalized cancer pain patients.

The purpose of this study is to assess the pain interference by using the Brief Pain Inventory (BPI) and to compare between the in-person group and the telemedicine group. To assess the cost-effectiveness of telemedicine for reducing symptoms associated with cancer and its treatment.

Description:

The pain interference will be assessed and compared using Brief Pain Inventory from 0-70 between In-person group and telemedicine group at 1 month.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 206
• Est. completion date: July 17, 2025
• Est. primary completion date: July 17, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age older than 18 years old

• Cancer patients who new visit as out patient at pain clinic, Siriraj hospital

Exclusion Criteria:

• Cannot read and write

• Confusion

• Unable to use the 0-10 Numerical Rating Scale (NRS) to rate pain intensity.

• Unstable clinical presentation

Related Conditions & MeSH terms

• Cancer Pain
• Chronic Pain
• Pain, Chronic

Intervention

Other:
• Telemedicine
Telemedicine
• In-person
In-person

Locations

Country	Name	City	State
Thailand	Faculty of medicine Siriraj Hospital Mahidol University	Bangkoknoi	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

References & Publications (4)

Chaudakshetrin P. Validation of the Thai Version of Brief Pain Inventory (BPI-T) in cancer patients. J Med Assoc Thai. 2009 Jan;92(1):34-40. — View Citation

Pang L, Liu Z, Lin S, Liu Z, Liu H, Mai Z, Liu Z, Chen C, Zhao Q. The effects of telemedicine on the quality of life of patients with lung cancer: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2020 Oct 7;11:2040622320961597. doi: 10.1177/20 — View Citation

Pattanaphesaj J, Thavorncharoensap M, Ramos-Goni JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L Valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):551-558. doi: 10.1080/14737167.2018.1494574. Epub 2018 Jul 6 — View Citation

Wangnamthip S, Panchoowong S, Donado C, Lobo K, Phankhongsap P, Sriveerachai P, Euasobhon P, Rushatamukayanunt P, Mandee S, Zinboonyahgoon N, Berde CB. The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain interference	The pain interference will be assessed and compared using Brief Pain Inventory from 0-70 between In-person group and telemedicine group.	at 1 month
Secondary	Quality of life (QoL)	The quality of life will be assessed and compared using EuroQoL 5D5L between In-person group and telemedicine group.	at 1 month
Secondary	Pain intensity	The pain reduction will be assessed and compared using numerical rating (NRS) from 0-10; 0 designating "no pain" and 10 designating " worst possible pain" scale between In-person group and telemedicine group.	at 1 month, 2 months and 3 months